Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P366: Long-term evolution of gastrointestinal immune-related adverse events (GI-IrAE) induced by immune checkpoint inhibitors (ICI)ECCO '18 Vienna
Year: 2018
Authors:

A. de Malet1*, G. Antoni2, E. Soularue1, M. Collins1, L. Marthey1, T. Vaysse1, C. Mateus3, C. Robert3, F. Carbonnel1

1Bicêtre Hospital - APHP, Gastro-enterology, Kremlin-Bicêtre, France, 2University Hospital Paul Brousse, Liver and biliary-tract disease center, Villejuif, France, 3Universite Paris Sud, Institut Gustave Roussy, Centre for Research in Epidemiology and Population Health / INSERM, UMRS 1018, Team 9, Villejuif, France

P367: Vedolizumab and early postoperative complications in non-intestinal surgery: A case-matched analysisECCO '18 Vienna
Year: 2018
Authors:

P.G. Kotze1*, N. Mckenna2, C. Ma1, A. Almutairdi1, L. Raffals3, E.V. Loftus Jr.3, R. Panaccione1, A. Lightner2

1University of Calgary, IBD Unit, Division of Gastroenterology and Hepatology, Calgary, Canada, 2Mayo Clinic Rochester, Division of Colorectal Surgery, Rochester, USA, 3Mayo Clinic Rochester, Division of Gastroenterology and Hepatology, Rochester, USA

P368: Persistence of biologic therapy and mapping of sequential biologic use: Results of a single centre cohort with 841 patients treated over 18 yearsECCO '18 Vienna
Year: 2018
Authors:

P. Jenkinson*, N. Plevris, C.S. Chuah, M. Lyons, G. Jones, R. Hall, I. Arnott, C. Lees

NHS Lothian, Gastroenterology, Edinburgh, UK

P369: Efficacy of infliximab after failure of subcutaneous anti-TNF agents in patients with ulcerative colitis: A multicentre studyECCO '18 Vienna
Year: 2018
Authors:

A. Streichenberger1*, B. Pariente2, A. Bozon3, N. Arab4, A. Amiot5, L. Vuitton6, M. Tilmant7, M. Nachury8, R. Altwegg3, T. Delasalle4, C. Gagnière5, B. Grégoire6, M. Fumery7, P. Wils2, G. Pineton de Chambrun3, X. Hébuterne4, B. Pereira9, G. Bommelaer1,10, A. Buisson1,10

1University Hospital Estaing, Gastroenterology Department, Clermont-Ferrand, France, 2University Hospital, Gastroenterology Department, Lille, France, 3CHU de Montpellier, Department of Gastroenterology, Montpellier, France, 4Archet 2 University Hospital, Department of Gastroenterology, Nice, France, 5Hospital Henri-Mondor, Department of Gastroenterology, Creteil, France, 6University Hospital of Besançon, Gastroenterology, Besançon, France, 7University Hospital, Gastroenterology Department, Amiens, France, 8University Hospital of Lille, Gastroenterology, Lille, France, 9University Hospital, Biostatistics Unit, DRCI, Clermont-Ferrand, France, 10UMR 1071 Inserm/Université d'Auvergne; USC-INRA 2018, Microbes, Intestine, Inflammation and Susceptibility of the Host, Clermont-Ferrand, France

P370: Endosponge-assisted early surgical closure of ileal pouch-anal anastomotic leakage improves long-term outcomesECCO '18 Vienna
Year: 2018
Authors:

K.A. Wasmann1*, M.A. Reijntjes1, M.E. Stellingwerf1, C.I. Ponsioen2, C.J. Buskens1, P.J. Tanis1, W.A. Bemelman1

1Academic Medical Center (AMC), Department of Surgery, Amsterdam, The Netherlands, 2Academic Medical Center (AMC), Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands

P371: Vedolizumab is associated with changes in innate rather than T-cell immunity in patients with inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

S. Zeissig1,2*, E. Rosati3, C.M. Dowds3,4, K. Aden2,3, J. Bethge2, B. Schulte2, W.H. Pan3, M. Falk-Paulsen3, C. Conrad2, D. Schuldt2, A. Sinha3, S. Nikolaus2, A. Arlt2, D. Kabelitz4, M. Ellrichmann2, P. Rosenstiel3, A. Franke3, S. Schreiber2,3

1University Medical Center Dresden, Department of Medicine I, Dresden, Germany, 2University Hospital Schleswig-Holstein, Department of Internal Medicine I, Kiel, Germany, 3University Hospital Schleswig-Holstein, Institute of Clinical Molecular Biology, Kiel, Germany, 4Christian-Albrechts-Universität zu Kiel, Institute of Immunology, Kiel, Germany

P372: A pilot study: A psychological support service for patients with inflammatory bowel disease (PSSPIBD)ECCO '18 Vienna
Year: 2018
Authors:

R. McGeer1*, A. Ascott1, J. Eccles2, M. Smith1, L. Page2, E. Hills1, A. St-clair Jones1, J. Gregory2

1Brighton and Sussex University Hospitals NHS Trust, UK, Gastroenterology, Brighton and Hove, UK, 2Sussex Partnership NHS Foundation Trust, UK, Liason Psychiatry, Brighton and Hove, UK

P373: Daily aspirin use does not impact clinical outcomes in patients with inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

P. Patel*, G. Gao, G. Gulotta, D.T. Rubin, S. Dalal, R.D. Cohen, A. Sakuraba, J. Pekow

University of Chicago, Chicago, USA

P374: Non-alcoholic fatty liver disease in inflammatory bowel disease: Prevalence and risk factorsECCO '18 Vienna
Year: 2018
Authors:

G. Losurdo1*, A. Iannone2, M. Mangia3, E. Shahini2, F. Albano2, S.F. Rizzi2, R.F. La Fortezza2, R. Lovero2, A. Contaldo2, M. Barone2, G. Leandro4, E. Ierardi2, A. Di Leo2, M. Principi2

1University of Bari, Department of Emergency and Organ Transplantation, Bari, Italy, 2University of Bari, DETO, Bari, Italy, 3Azienda Ospedaliera Consorziale Policlinico, Bari, Italy, 4IRCCS Saverio de Bellis, Department of Gastroenterology and Digestive Endoscopy, Castellana Grotte, Italy

P375: Self-management in inflammatory bowel disease: A perspective of patients and caretakersECCO '18 Vienna
Year: 2018
Authors:

N. Peek-Kuijt*, S. van den Burg, A. van der Meulen- de Jong, J. Maljaars

Leiden University Medical Center, Gastroenterology, Leiden, The Netherlands

P376: Clinical effectiveness of vedolizumab in a tertiary care cohort of IBD patientsECCO '18 Vienna
Year: 2018
Authors:

S. Bots1*, E. van Baalen2, N. de Boer3, K. Gecse2, C. Ponsioen2, G. D'Haens2, M. Löwenberg2

1Academic Medical Centre (AMC), Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands, 2Academic Medical Center (AMC), Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands, 3VuMC, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands

P377: Complications related to varicella zoster virus infection in patients with inflammatory bowel disease in the pre-JAK inhibitors era: A prospective studyECCO '18 Vienna
Year: 2018
Authors:

R. de Francisco1,2*, A. Castaño1, P. Flórez-Díez1, S. Martínez-González1, I. Pérez-Martínez1, N. Rodríguez-Ferreiro1, V. Jiménez-Beltrán1, A. Suárez1,2, S. Riestra1,2

1Hospital Universitario Central de Asturias, Gastroenterology, Oviedo, Spain, 2Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain

P378: Immunisation practices for hepatitis B and response to vaccination in Greek patients with inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

D. Kalogera1*, S. Siakavellas1, E. Zambeli2, E. Tsironi3, M. Tzouvala4, D. Moschovis4, A. Kostas1, G. Axiaris2, E. Kourkoutas2, K. Filippakou3, J. Vlachogiannakos1, S. Michopoulos2, G. Papatheodoridis1, G. Bamias5

1National and Kapodistrian University of Athens, Laiko General Hospital, Academic Department of Gastroenterology, Athens, Greece, 2Alexandra Hospital, Gastroenterology Unit, Athens, Greece, 3Metaxa Memorial Cancer Hospital of Piraeus, Department of Gastroenterology, Athens, Greece, 4General Hospital of Nikea and Piraeus Agios Panteleimon, Department of Gastroenterology, Athens, Greece, 5on behalf of the Greek Vedolizumab Study group, Athens, Greece

P379: Infliximab or adalimumab: Which should be used first for Crohn’s disease? A multicentre retrospective observational studyECCO '18 Vienna
Year: 2018
Authors:

S. Takahashi1*, T. Inokuchi2, S. Hiraoka2, T. Toyokawa3, S. Takagi4, K. Takemoto5, J. Miyaike6, T. Fujimoto7, R. Higashi8, H. Yasuhara9, T. Nawa10, S. Suzuki11, J. Kato12, H. Okada2

1Kagawa Prefectural Central Hospital, Department of gastroenterology, Takamatsu, Japan, 2Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Department of Gastroenterology and Hepatology, Okayama city, Japan, 3National Hospital Organization Fukuyama Medical center, Department of Gastoenterology, Fukuyama city, Japan, 4Japanese Red Cross Society Himeji Hospital, Department of Internal Medicine, Himeji city, Japan, 5Tsuyama chuo Hospital, Depatment of Gastroenterology, Tsuyama city, Japan, 6Saiseikai Imabari Hospital, Department of Internal medicine, Imabari city, Japan, 7Iwakuni medical center, Department of Gastroenterology, Iwakuni, Japan, 8Hiroshima City Hiroshima Citizens Hospital, Department of Gastroenterology, Hiroshima city, Japan, 9Mitoyo General Hospital, Department of Gastroenterology, Mitoyo City, Japan, 10Fukuyama City hospital, Department of gastroenterology, Fukuyama City, Japan, 11Sumitomo Besshi Hospital, Department of Internal medicine, Niihama city, Japan, 12Wakayama Medical University, Second Department of Internal Medicine, Wakayama City, Japan

P380: Risk factors for poor postoperative outcome in patients with Crohn’s disease undergoing ileocaecal resectionECCO '18 Vienna
Year: 2018
Authors:

A. Labidi1*, M. Ben Abbes1, S. Hamdi1, H. Maghrebi2, N. Ben Mustapha1, M. Fekih1, L. Zouiten1, M. Serghini1, Z. Ben Safta2, J. Boubaker1

1Rabta Hospital, Gastroenterology "A", Tunis, Tunisia, 2Rabta Hospital, Surgery "A", Tunis, Tunisia

P381: Predictors of vedolizumab response to induction: Real-life experienceECCO '18 Vienna
Year: 2018
Authors:

A. Gutiérrez1,2*, L. Sempere1, M. Belvis3, J.M. Vázquez4, R. Laveda5, M. García6, F. Argüelles-Arias3, H. Pallarés4, L. Castro3, E. Gómez4, B. Maldonado3

1Hospital General Universitario Alicante, Alicante, Spain, 2CIBERehd, Madrid, Spain, 3Hospital Universitario Virgen Macarena, Sevilla, Spain, 4Hospital Juan Ramón Jiménez, Huelva, Spain, 5Hospital San Juan, Alicante, Spain, 6Hospital General Universitario Elche, Elche, Spain

P382: CRP/albumin ratio: Predictive factor of the response to corticosteroids in acute severe colitisECCO '18 Vienna
Year: 2018
Authors:

S. Jardak1*, M. Medhioub2, K. Agar2, L. Hamzaoui1,2,3, A. Khsiba2, M.M. Azouz2

1Nabeul-Tunisia, Department of gastroenterology Nabeul-Tunisia, Nabeul, Tunisia, 2Nabeul-Tunisia, Nabeul-Tunisia, Nabeul, Tunisia, 3Mohamed Taher Maamouri Hospital, Department of Gastroenterology, Nabeul, Tunisia

P383: Breast feeding practices differ between mothers with IBD and mothers without IBDECCO '18 Vienna
Year: 2018
Authors:

C. Baker1, V. Nguyen2, S. Andriasak2, L. Ambrosio3, K.-A. Berga1, L. Dieleman3, B. Halloran3, K.I. Kroeker3, F. Peerani3, K. Wong3, V.W. Huang3*, R.N. Fedorak3

1Grant MacEwan, Edmonton, Canada, 2University of Alberta, Edmonton, Canada, 3University of Alberta, Gastroenterology, Edmonton, Canada

P384: Gari-leo prospective study on anti-TNF therapy in ulcerative colitis relapse patientsECCO '18 Vienna
Year: 2018
Authors:

S. Kato*, K. Kani, A. Ishibashi, M. Oka, S. Nagoshi, K. Yakabi

Saitama Medical Center, Saitama Medical University, Department of Gastroenterology and Hepatology, Kawagoe City, Saitama, Japan

P385: Colectomy-free survival and factors associated with it in children with ulcerative colitis managed in a tertiary IBD centre in the UKECCO '18 Vienna
Year: 2018
Authors:

S.-Y. Ong*, W. Haller, R. Muhammed

Birmingham Children's Hospital, Gastroenterology, Birmingham, UK